GlassScriptPhysician profile
Matthew Cascio
NPI 1952921447
$5,035.69
in general payments reported to CMS, 2019-2025
9 companies · $920 in 2025
The $920 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,116 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,000 · Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,000.00 |
| Food and Beverage | $1,035.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,394.54 | 2024-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Spr Therapeutics, INC | $286.09 | 2024-2025 | Sprint Pns System |
| Nalu Medical, INC. | $136.98 | 2025 | Nalu Neurostimulation System |
| Abbvie INC. | $67.33 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $56.59 | 2025 | |
| Biotronik Nro, INC. | $26.57 | 2025 | Prospera |
| Boston Scientific Corporation | $25.81 | 2025 | Intracept |
| Collegium Pharmaceutical, INC. | $23.51 | 2025 | Xtampza |
| Stryker Corporation | $18.27 | 2025 | Optablate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Cascio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.